97.77
Irhythm Technologies Inc stock is traded at $97.77, with a volume of 258.69K.
It is down -3.85% in the last 24 hours and down -12.85% over the past month.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$101.69
Open:
$101.14
24h Volume:
258.69K
Relative Volume:
0.64
Market Cap:
$3.07B
Revenue:
$560.03M
Net Income/Loss:
$-150.66M
P/E Ratio:
-20.12
EPS:
-4.86
Net Cash Flow:
$-87.43M
1W Performance:
-3.57%
1M Performance:
-12.85%
6M Performance:
+27.62%
1Y Performance:
-6.67%
Irhythm Technologies Inc Stock (IRTC) Company Profile
Name
Irhythm Technologies Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
IRTC
Irhythm Technologies Inc
|
97.77 | 3.07B | 560.03M | -150.66M | -87.43M | -4.86 |
![]()
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
Oct-04-24 | Initiated | Goldman | Neutral |
Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
Jul-19-23 | Initiated | Robert W. Baird | Outperform |
Feb-07-23 | Initiated | Wells Fargo | Overweight |
Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
Apr-06-22 | Initiated | Wolfe Research | Underperform |
Feb-24-22 | Upgrade | Needham | Hold → Buy |
Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
Dec-21-21 | Resumed | Canaccord Genuity | Buy |
Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
Jan-29-21 | Reiterated | Needham | Hold |
Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
Sep-11-20 | Initiated | Needham | Hold |
Sep-02-20 | Initiated | Robert W. Baird | Neutral |
Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
Mar-05-20 | Initiated | Citigroup | Buy |
Feb-06-20 | Initiated | BTIG Research | Buy |
Jan-10-20 | Initiated | William Blair | Outperform |
Jan-08-20 | Initiated | SunTrust | Buy |
Oct-22-19 | Initiated | Oppenheimer | Perform |
Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Technologies Inc Stock (IRTC) Latest News
iRhythm Technologies Inc (IRTC) Shares Gap Down to $83.555 on De - GuruFocus.com
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD) - Barchart
When the Price of (IRTC) Talks, People Listen - Stock Traders Daily
Shareholders that lost money on iRhythm Technologies, Inc.(IRTC) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Despite currently being unprofitable, iRhythm Technologies (NASDAQ:IRTC) has delivered a 28% return to shareholders over 5 years - Simply Wall St
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Principal Financial Group Inc. - Defense World
iRhythm Technologies, Inc. to Host Earnings Call - ACCESS Newswire
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stake Raised by Bank of New York Mellon Corp - Defense World
Unveiling iRhythm Technologies (IRTC)'s Value: Is It Really Pric - GuruFocus.com
Versor Investments LP Acquires Shares of 2,780 iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
LAWSUIT FILED: Block & Leviton LLP Reminds Investors that it Has Filed a Lawsuit Against iRhythm Technologies, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm - ACCESS Newswire
iRhythm technologies EVP sells $187,737 in stock By Investing.com - Investing.com South Africa
iRhythm technologies CEO sells $885,931 in stock By Investing.com - Investing.com South Africa
iRhythm technologies CFO sells $254,630 in stock By Investing.com - Investing.com Canada
iRhythm technologies CFO sells $254,630 in stock - Investing.com
iRhythm Technologies’ chief commercial officer sells shares for $299,770 - Investing.com
iRhythm technologies CEO sells $885,931 in stock - Investing.com
IRTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
IRTC LAWSUIT ALERT: Levi & Korsinsky Notifies iRhythm Technologies, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
IRTC SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRhythm Technologies, Inc. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
Shareholders of iRhythm Technologies, Inc. Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your RightsIRTC - ACCESS Newswire
iRhythm Technologies (NASDAQ:IRTC) Stock Rating Upgraded by StockNews.com - MarketBeat
Levi & Korsinsky Notifies Shareholders of iRhythm Technologies, Inc.(IRTC) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
How To Trade (IRTC) - Stock Traders Daily
Shareholders that lost money on iRhythm Technologies, Inc. (IRTC) should contact Levi & Korsinsky about pending Class ActionIRTC - ACCESS Newswire
Levi & Korsinsky Reminds iRhythm Technologies, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 8, 2024IRTC - ACCESS Newswire
Irhythm Technologies Executives Cash In: Massive Stock Sales Unveiled! - TipRanks
iRhythm technologies’ CBO and CLO Murphy sells $1.79 million in stock By Investing.com - Investing.com South Africa
iRhythm Technologies, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before April 8, 2024 to Discuss Your RightsIRTC - ACCESS Newswire
Investors in iRhythm Technologies, Inc. Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your RightsIRTC - ACCESS Newswire
iRhythm technologies CFO Wilson sells $281,670 in stock By Investing.com - Investing.com Canada
iRhythm Technologies EVP Turakhia Minang sells $786,479 in stock By Investing.com - Investing.com Canada
Lost Money on iRhythm Technologies, Inc. (IRTC)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
New York State Common Retirement Fund Has $11.50 Million Stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm technologies CEO Blackford sells $2.5m in stock By Investing.com - Investing.com Australia
iRhythm technologies EVP sells $890,536 in stock By Investing.com - Investing.com South Africa
iRhythm Technologies EVP Turakhia Minang sells $786,479 in stock - Investing.com
iRhythm technologies EVP sells $890,536 in stock - Investing.com
iRhythm technologies CEO Blackford sells $2.5m in stock - Investing.com India
iRhythm technologies’ CBO and CLO Murphy sells $1.79 million in stock - Investing.com India
iRhythm technologies CFO Wilson sells $281,670 in stock - Investing.com
UPCOMING IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
This Stock's Vital 🫀 Signs Are Strong! - substack.com
iRhythm Technologies (NASDAQ:IRTC) Rating Increased to Hold at StockNews.com - Defense World
IMMINENT IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Truist lifts iRhythm stock price target to $145, maintains buy By Investing.com - Investing.com Canada
Truist lifts iRhythm stock price target to $145, maintains buy - Investing.com
Van ECK Associates Corp Boosts Stock Position in iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World
Needham & Company LLC Boosts iRhythm Technologies (NASDAQ:IRTC) Price Target to $138.00 - Defense World
iRhythm Technologies Faces Financial Risks from Convertible Debt Accounting Practices - MSN
Irhythm Technologies Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):